Start the conversation
Just weeks ago, the mainstream media was still talking about an alleged correction for tech stocks.
However, I see things much differently. The tech-centric Nasdaq Composite Index has gained some 6.5% so far this year. That's more than double the Dow Jones Industrial Average's 3% gain.
This is great news I just had to share with you.
Folks in Silicon Valley have a term they use to describe a company that wants to keep its operations quiet.
They call it "Stealth Mode"…
The term applies to a startup that's hiring, raising funds, and developing a product – but is operating in secret to keep its competitors in the dark.
"Stealth Mode" also could describe this quiet – but substantial – rally tech stocks have been in nearly all year and especially during the last three months.
While the media was focused on the Dow recently hitting a record 17,000, the Nasdaq has done twice as well. All the while, Wall Street and the mainstream financial media have kept quiet about it.
About 15 months ago, I noted that well over half of all Americans have less than $25,000 in savings – and can't afford to retire. That number hasn't changed much overall… but I know it's changing for you.
After all, at the same time, I told you that the road to wealth is paved with tech.
This has long been true – from the lightbulb, the radio, the television, and the airplane in the past to transistors, semiconductors, computers, software, the web, and smartphones today.
And these midyear numbers prove this trend is showing no signs of slowing down.
Today, I want to talk with you about why I think tech stocks will continue climbing for the rest of this year.
And I'm sharing with you three great ways to not only play the Stealth Tech Rally… but also to continue filling your retirement war chest with more and more gold…
Tech Stocks Are the Real Winners
It's true that the Standard & Poor's 500 is ahead of the Nasdaq so far this year. With a year-to-date gain of 7.5%, it's doing about 14% better.
But that advantage disappears when you look at what's happened over the last three months. During that time, the Nasdaq has gained some 9.75%, beating the S&P's gains by 30%.
By just about anyone's standards, that's a decisive victory.
While I'm especially hot on tech, I also still expect a strong 2014 for the overall market. And I'm basing that prediction on the following key economic factors.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.